Holen Sie sich die Stockscreener-App
45.22
2.61%
-1.21
Vorhandelsmarkt:
43.86
-1.36
-3.01%
Schlusskurs vom Vortag:
$46.43
Offen:
$45.54
24-Stunden-Volumen:
15,513
Relative Volume:
0.43
Marktkapitalisierung:
$276.53M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.12M
KGV:
-19.66
EPS:
-2.3
Netto-Cashflow:
$-6.82M
1W Leistung:
+13.73%
1M Leistung:
+37.61%
6M Leistung:
+34.30%
1J Leistung:
+7,021%
1-Tages-Spanne:
$44.26
$45.54
1-Wochen-Bereich:
$39.56
$50.14
52-Wochen-Spanne:
$0.3438
$54.30
Monopar Therapeutics Inc Stock (MNPR) Company Profile
Firmenname
Monopar Therapeutics Inc
Sektor
Branche
Telefon
(847) 388-0349
Adresse
1000 SKOKIE BLVD SUITE 350, WILMETTE
Vergleichen Sie MNPR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MNPR
Monopar Therapeutics Inc
|
45.22 | 243.14M | 0 | -7.12M | -6.82M | -2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-06-23 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-19 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-01-10 | Eingeleitet | Piper Sandler | Overweight |
| 2024-10-11 | Eingeleitet | Rodman & Renshaw | Buy |
| 2021-01-28 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Monopar Therapeutics Inc Aktie (MNPR) Neueste Nachrichten
What analysts say about Monopar Therapeutics Inc. stockExponentially increasing returns - Autocar Professional
What drives Monopar Therapeutics Inc. stock pricePhenomenal returns - jammulinksnews.com
Monopar Therapeutics Inc. Stock Analysis and ForecastBreakthrough profits - jammulinksnews.com
Is Monopar Therapeutics Inc. a good long term investmentOutstanding capital returns - jammulinksnews.com
Long Term Trading Analysis for (MNPR) - news.stocktradersdaily.com
Is TBMCR a good long term investmentExplosive trading opportunities - jammulinksnews.com
Technical Analysis: Sreeleathers Limited (535601)Tremendous portfolio expansion - jammulinksnews.com
Is Siddhi Acquisition Corp. Debt Equity Composite Units a good long term investmentMarket-crushing profits - jammulinksnews.com
Las Vegas Sands Corp. Stock Analysis and ForecastMassive wealth growth - jammulinksnews.com
Best Stocks for Risk Averse Investors Market Trend Prediction ToolsFree Stock Chart Pattern Guide - jammulinksnews.com
Monopar Therapeutics Inc. (NASDAQ:MNPR) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
When is the best time to buy Monopar Therapeutics Inc. stockFree Professional Portfolio Management - Newser
What analysts say about Monopar Therapeutics Inc. stock outlook5x Profit Potential - Newser
Why Monopar Therapeutics Inc. stock attracts strong analyst attentionProfit Focused Trade Alerts - beatles.ru
Monopar therapeutics director Tsuchimoto sells $356k in stock By Investing.com - Investing.com Canada
Monopar therapeutics director Starr sells $672k in stock By Investing.com - Investing.com Canada
Monopar therapeutics CEO Chandler Robinson sells $672k in stock By Investing.com - Investing.com Canada
Monopar Therapeutics Executives Buy and Sell Shares Amid Recent Volatility. - AInvest
how monopar therapeutics inc. stock performs during market volatilityFree Day Trading Recommendations - Newser
How Monopar Therapeutics Inc. stock performs during market volatilityFree Low-Risk Investment Plans - Newser
What makes Monopar Therapeutics Inc. stock price move sharplyAnalyst Grade Signals - Newser
(MNPR) Trading Advice - news.stocktradersdaily.com
Wall Street Analysts Predict a 51.26% Upside in Monopar Therapeutics (MNPR): Here's What You Should Know - MSN
Analysts Set Expectations for MNPR FY2025 Earnings - Defense World
Monopar Therapeutics (NASDAQ:MNPR) Coverage Initiated by Analysts at Cantor Fitzgerald - Defense World
Monopar Therapeutics Inc.(NasdaqCM: MNPR) added to Russell 2000 Index - MarketScreener
Equities Analysts Offer Predictions for MNPR FY2025 Earnings - Defense World
Chardan Initiates Coverage of Monopar Therapeutics (MNPR) Stock, Gives Buy - Yahoo Finance
Institutional investors own a significant stake of 29% in Monopar Therapeutics Inc. (NASDAQ:MNPR) - Yahoo Finance
Monopar Therapeutics (NASDAQ:MNPR) Trading 0.4% Higher – Time to Buy? - Defense World
Finanzdaten der Monopar Therapeutics Inc-Aktie (MNPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):